A double knockout of these two transcription factors shifted CAR-T-cell phenotypes away from TIM-3+CD8+ toward TCF1+CD8+ to counteract the exhaustion of tumor-infiltrating CAR-T-cells, enhancing their antitumor activity in mouse models [163]. The gene discussed is CD8A; the disease is neoplasm.